Brian Taylor Slingsby, Director of Mineralys Therapeutics MLYS, has filed 2 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $46.4M. The latest trade was on 09/22.

BS

BS

Brian Taylor Slingsby

Director

Company

Mineralys Therapeutics MLYS

First filing

23/02/13

Trades

23 trades

Buys / sales

2 / 3

12-month net buying

−$46.4M

Last trade

09/22

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Mineralys TherapeuticsMLYS	Open-market sale	09/22	09/24	104,320 sh	$28.81	$3,005,302.72	−1.3%
Mineralys TherapeuticsMLYS	Open-market sale	25/11/20	25/11/21	1,000,000 sh	$43.35	$43,350,000	−11.2%
Mineralys TherapeuticsMLYS	Open-market buy	25/03/13	25/04/25	259,259 sh	$13.50	$3,499,996.5	+3.0%
Mineralys TherapeuticsMLYS	Open-market sale	24/07/24	24/07/26	550,000 sh	$13.05	$7,177,500	−6.0%
Mineralys TherapeuticsMLYS	Open-market buy	23/02/14	23/02/16	250,000 sh	$16.00	$4,000,000	+2.8%